<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02353975</url>
  </required_header>
  <id_info>
    <org_study_id>SHR3824-104</org_study_id>
    <nct_id>NCT02353975</nct_id>
  </id_info>
  <brief_title>Effect of a High-fat Meal on the Pharmacokinetics of SHR3824 and Mass Balance Study in Healthy Subjects</brief_title>
  <official_title>An Open Label, Randomized, Two-period, Crossover Study to Assess the Effect of Food on SHR3824 and Mass Balance Study in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jiangsu HengRui Medicine Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jiangsu HengRui Medicine Co., Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This open-label, randomized, two-period, two-treatment (single doses of 10 mg SHR3824 fasted
      or fed), crossover study was conducted to evaluate the effect of a high-fat meal on the
      pharmacokinetics of SHR3824 and mass balance study in 12 healthy subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The maximum plasma concentration (Cmax) of SHR3824</measure>
    <time_frame>Day 1-4 on visit 2 and visit 3</time_frame>
    <description>Cmax (a measure of the body's exposure to SHR3824) will be compared under fating state and fasted state</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The area under the plasma concentration-time curve (AUC) of SHR3824</measure>
    <time_frame>Day 1-4 on visit 2 and visit 3</time_frame>
    <description>AUC (a measure of the body's exposure to SHR3824) will be compared under fating state and fasted state</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The accumulative excretion rate of SHR3824 and its metabolites in urine and feces</measure>
    <time_frame>Day 1-4 on visit 2 and visit 3</time_frame>
    <description>Accumulative excretion rate will be compared under fating state and fasted state</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The number of volunteers with adverse events as a measure of safety and tolerability.</measure>
    <time_frame>Up to Day 12</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>SHR3824 10mg fasted to fed</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SHR3824 tablet, fasting conditions day 1, visit 2, 7 days wash-out, SHR3824 tablet, high fat, high calorie breakfast day 1, visit 3.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SHR3824 10mg fed to fasted</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SHR3824, high fat, high calorie breakfast day 1, visit 2, 7 days wash-out, SHR3824, fasting conditions day 1, visit 3.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SHR3824</intervention_name>
    <description>SHR3824 tablet,10mg, fasting conditions and high fat, high calorie breakfast.</description>
    <arm_group_label>SHR3824 10mg fasted to fed</arm_group_label>
    <arm_group_label>SHR3824 10mg fed to fasted</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy.

          -  BMI 18-25 kg/m2.

        Exclusion Criteria:

          -  History of clinically significant illness.

          -  History of alcohol or drug abuse.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 20, 2015</study_first_submitted>
  <study_first_submitted_qc>February 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2015</study_first_posted>
  <last_update_submitted>February 2, 2015</last_update_submitted>
  <last_update_submitted_qc>February 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>SHR3824</keyword>
  <keyword>food effect</keyword>
  <keyword>mass</keyword>
  <keyword>balance</keyword>
  <keyword>Phase I</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

